Expression of CD44 splicing isoforms in lung cancers: Dominant expression of CD44v8-10 in non-small cell lung carcinomas

International Journal of Oncology

Volumn 12, Issue 3, 1998, Pages 525-533

  Sasaki, J I Ichiro ^a   Tanabe, Kenneth K ^b   Takahashi, Kazuhisa ^b   Okamoto, Isamu ^a   Fujimoto, Hisao ^a   Matsumoto, Mitsuhiro ^a   Suga, Moritaka ^a   Ando, Masayuki ^a   Saya, Hideyuki ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Adhesion molecule; Alternative splicing; CD44; Immunohistochemistry; Lung cancer

Indexed keywords

4 DIMETHYLAMINOAZOBENZENE; ANTIBODY; HERMES ANTIGEN; MESSENGER RNA; PHOSPHATE; TUMOR MARKER;

ALTERNATIVE RNA SPLICING; ANTIGEN EXPRESSION; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; FILTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; LUNG DISEASE; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031882175     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.12.3.525     Document Type: Article

References (40)

1. Minna JD, Pass H, Glatstein E and Ihde DC: Lung cancer. In: Cancer: Principles and Practice of Oncology. Devita VT, Hellman S and Rosenberg SA (eds). Lippincott, Philadelphia, pp591-687, 1989.
2. Minna JD: The molecular biology of lung cancer pathogenesis. Chest 103: 449S-456S, 1993.
3. Aruffo A, Stamenkovic I, Melnick M, Underbill CB and Seed B: CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303-1313, 1990.
4. Stamenkovic I, Amiot M, Pesando JM and Seed B: A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 56: 1057-1062, 1989.
5. Seth A, Gote L, Nagarkatti M and Nagarkatti PS: T-cell-receptor-independent activation of cytolytic activity of cytotoxic » T lymphocytes mediated through CD44 and gp90MEL-14. Proc Natl Acad Sci USA 88: 7877-7881, 1991.
6. Hardwick C, Hoare K, Owens R, Hohn HP, Hook M, Moore D, Cripps V, Austen L, Nance DM and Turley EA: Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility. J Cell Biol 117: 1343-1350, 1992.
7. Bartolazzi A, Peach R, Aruffo A and Stamenkovic I: Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J Exp Med 180: 53-66, 1994.
8. Reber S, Matzku S, Gunthert U, Ponta H, Herrlich P and Zoller M: Retardation of metastatic tumor growth after immunization with metastasis-specific monoclonal antibodies. Int J Cancer 46: 919-927, 1990.
9. Gunthert U, Hofmann M, Rudy W, Reber S, Zoller M, Haussmann I, Matzku S, Wenzel A, Ponta H and Herrlich P: A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65: 13-24, 1991.
10. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U and Bell JI: Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 89: 12160-12164, 1992.
11. Tanabe KK, Nishi T and Saya H: Novel variants of CD44 arising from alternative splicing: changes in the CD44 alternative splicing pattern of MCF-7 breast carcinoma cells treated with hyaluronidase. Mol Carcinogen 7: 212-220, 1993.
12. Tolg C, Hofmann M, Herrlich P and Ponta H: Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res 21: 1225-1229, 1993.
13. Jackson DG, Buckley J and Bell JI: Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain. J Biol Chem 267:4732-4739, 1992.
14. Nagasaka S, Tanabe KK, Bruner JM, Saya H, Sawaya RE and Morrison RS: Alternative RNA splicing of the hyaluronic acid receptor CD44 in the normal human brain and in brain tumors. J Neurosurg 82: 858-863, 1995.
15. Fox SB, Fawcett J, Jackson DG, Collins I, Gatter KC, Harris AL, Gearing A and Simmons DL: Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res 54: 4539-4546, 1994.
16. Mackay CR, Terpe HJ, Stauder R, Marston WL, Stark H and Gunthert U: Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 124: 71-82, 1994.
17. Tanabe KK, Ellis LM and Saya H: Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet 341:725-726, 1993.
18. Takahashi K, Stamenkovic I, Cutler M, Dasgupta A and Tanabe KK: Keratan sulfate modification of CD44 modulates adhesion to hyaluronate. J Biol Chem 271: 9490-9496, 1996.
19. Tanabe KK, Stamenkovic I, Cutler M and Takahashi K: Restoration of CD44H expression in colon carcinomas reduces tumorigenicity. Ann Surg 222:493-501, 1995.
20. Yamaguchi A, Urano T, Goi T, Saito M, Takeuchi K, Hirose K, Nakagawara G, Shiku H and Furukawa K: Expression of a CD44 variant containing exons 8 to 10 is a useful independent factor for the prediction of prognosis in colorectal cancer patients. J Clin Oncol 14: 1122-1127, 1996.
21. Matsumura Y and Tarin D: Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 340: 1053-1058, 1992.
22. Mulder JW, Kruyt PM, Sewnath M, Costing J, Seldenrijk CA, Weidema WF, Offerhaus GJ and Pals ST: Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 344: 1470-1472, 1994.
23. Kaufmann M, Heider KH, Sinn HP, von Minckwitz G, Ponta H and Herrlich P: CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 345: 615-619, 1995.
24. Manten HE, Danen EH, Smit L, Snoek M, Le PI, Van MG, Pals ST and Ruiter DJ: Expression of CD44 splice variants in human cutaneous melanoma and melanoma cell lines is related to tumor progression and metastatic potential. Int J Cancer 64: 182-188, 1995.
25. Matsumura Y, Hanbury D, Smith J and Tarin D: Non-invasive detection of malignancy by identification of unusual CD44 gene activity in exfoliated cancer cells. BMJ 308: 619-624, 1994.
26. Yoshida K, Bolodeoku J, Sugino T, Goodison S, Matsumura Y, Warren BF, Toge T, Tahara E and Tarin D: Abnormal retention of intron 9 in CD44 gene transcripts in human gastrointestinal tumors. Cancer Res 55: 4273-4277, 1995.
27. Matsumura Y, Sugiyama M, Matsumura S, Hayle AJ, Robinson P, Smith JC and Tarin D: Unusual retention of introns in CD44 gene transcripts in bladder cancer provides new diagnostic and clinical oncological opportunities. J Pathol 177: 11-20, 1995.
28. Washimi O, Ueda R, Ariyoshi Y, Suyama M, Seki T, Takahashi T and Takahashi T: Expression of CD44 variant isoforms in normal and neoplastic cells of the lung. Jpn J Cancer Res 85: 1112-1116, 1994.
29. Jackson DG, Schenker T, Waibel R, Bell JI and Stahel RA: Expression of alternatively spliced forms of the CD44 extracellular-matrix receptor on human lung carcinomas. Int J Cancer Suppl 8: 110-115, 1994.
30. Clarke MR, Landreneau RJ, Resnick NM, Crowley R, Dougherty GJ, Cooper DL and Yousem SA: Prognostic significance of CD44 expression in adenocarcinoma of the lung. J Clin Pathol Mol Pathol 48: 200-204, 1995.
31. Ariza A, Mate JL, Isamat M, Lopez D, von Uexkull-Guldeband C, Rossel R, Fernandes-Vasalo A and Navas-Palacios JJ: Standard and variant CD44 isoforms are commonly expressed in lung cancer of the non-small cell type but of the small cell type. J Pathol 177: 363-368, 1995.
32. Givehchian M, Woerner SM, Lacroix J, Zoller M, Drings P, Becker H, Kayser K, Ridder R and von Knebel DM: Expression of CD44 splice variants in normal respiratory epithelium and bronchial carcinomas: no evidence for altered CD44 splicing in metastasis. Oncogene 12: 1137-1144, 1996.
33. Wimmel A, Schilli M, Kaiser U, Havemann K, Ramaswamy A, Branscheid D, Kogan E and Schuermann M: Preferential histotypic expression of CD44-isoforms in human lung cancer. Lung Cancer 16: 151-172, 1997.
34. Penno MB, August JT, Baylin SB, Mabry M, Linnoila RI, Lee VS, Croteau D, Yang XL and Rosada C: Expression of CD44 in human lung tumors. Cancer Res 54: 1381-1387, 1994.
35. Birch M, Mitchell S and Hart IR: Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44. Cancer Res 51: 6660-6667, 1991.
36. Takahashi K, Stamenkovic I, Cutler M, Saya H and Tanabe KK: CD44 hyaluronate binding influences growth kinetics and tumorigenicity of human colon carcinomas. Oncogene 11: 2223-2232, 1995.
37. Dasgupta A, Takahashi K, Cutler M and Tanabe KK: O-linked glycosylation modifies CD44 adhesion to hyaluronate in colon carcinoma cells. Biochem Biophys Res Commun 227: 110-117, 1996.
38. Van der Voort R, Manten HE, Smit L, Ostermann E, van den Berg F and Pals ST: Binding of cell-surface expressed CD44 to hyaluronate is dependent on splicing and cell type. Biochem Biophys Res Commun 214: 137-144, 1995.
39. Hofmann M, Rudy W, Zoller M, Tolg C, Ponta H, Herrlich P and Gunthert U: CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res 51: 5292-5297, 1991.
40. Okamoto I, Morisaki T, Sasaki J, Miyake H, Matsumoto M, Suga M, Ando M and Saya H: Molecular detection of cancer cells by competitive reverse transcription-polymerase chain reaction analysis specific CD44 variant RNAs. J Natl Cancer Inst (In press).